Market access is wrapped in the politics of health The attention politicians and stakeholders pay to healthcare and its challenges is a keen driver of the ease or difficulty companies experience with drug regulation and market access and has implications… Read More »The politics of market access
We are in a new world when it comes to access to and the use of data and evidence. Real world data and evidence takes us from structured studies to the routine delivery of healthcare, actual use of a medicine,… Read More »Real world data and evidence in healthcare: The market access challenge
To some extent Academic Health Science Centres [AHSCs] are caught between the research push and market pull. If they prioritise technology transfer, they opt for a research push approach that emphasises the availability of technologies or innovations for market-based actors… Read More »Innovation and Academic Health Science Centres
It is not unreasonable to have concerns about the cost of medicines. Drug costs are usually influenced by government policies on pricing and reimbursement of medicines themselves. These range from simple discount seeking to more complex approaches such as conditional… Read More »Managerial control of medicines cost drivers
Healthcare systems have been slowly evolving toward a model of care delivery that seeks to leave behind the traditional medical model, based on fighting diseases – sometimes called the lesion-theory of medicine – and which has driven health care thinking… Read More »Healthcare Cognology: autonomous agency for patient empowerment and system reform
Discussions on health literacy are increasing as healthcare providers, clinicians, payers and patients consider what this means for healthcare. Having been involved in launching the world’s first digital interactive health channel in the UK in 2000, one thing I learned… Read More »9 Tribes of the Internet and their health interests
Andrew Yang is a democrat contender for president of the United States. He has expressed concern about a ‘jobless future’ as Martin Ford puts it [Rise of the Robots: Technology and the Threat of a Jobless Future], from technological change,… Read More »Should robots pay taxes?
Pain is, well, a pain. It is the one thing we all have direct experience of, and can communicate to others, but which defies direct clinical measurement. We are left with subjective measures of pain, such as the ‘oucher’ scale… Read More »Pain
The relevance of value in establishing the positioning of medicines is the new normal for pharmaceutical marketing. Pharmaceutical companies have customers who are highly constrained by whether healthcare system funding is sustainable long term. Remember, payers think epidemiologically and in… Read More »Positioning drugs in markets: how payers determine value
The AI agenda is for me all about augmenting human reasoning; what I call cognology (cognitive focus) to distinguish from technology (physical focus). This is the core challenge to work flow and adoption. Here are some thoughts on the application… Read More »A model for mapping machine learning onto human decision making